We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
Giacomo Quattrocchio, MD
Lynn D. Cornell, MD
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
John H. Stone, MD, MPH
Bart K. Chwalisz, MD
Marcela Marsiglia, MD, PhD
Consensus Recommendations for Use of p16/Ki-67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV
Warner K. Huh, MD
Kimberly Levinson, MD, MPH
Unlocking the Potential of TROP2-Targeted Therapy: Breakthroughs in NSCLC Therapeutic Approaches
Benjamin Levy, MD
Alexander Spira, MD, PhD, FACP
Unlocking the Potential of HER3-Targeted Therapy: Breakthroughs in EGFR-Mutant NSCLC Therapeutic Approaches
Jyoti Patel, MD
Pasi Antero Jänne, MD, PhD
Unlocking the Potential of HER2-Targeted Therapy: Breakthroughs in NSCLC Therapeutic Approaches
Helena Yu, MD
Later-Line Targeted Therapies for ROS1 Fusion-Positive Lung Cancers
Alexander Drilon, MD
Overcoming Acquired TKI-Resistance with Next-generation ROS1-TKI Agents
Charu Aggarwal, MD, MPH
The Role of Chemotherapy and Immunotherapy in ROS1-Rearranged NSCLC
Next-Generation TKI Therapy for ROS1-Rearranged NSCLC
Safety and Tolerability of ROS1 Tyrosine Kinase Inhibitors
Intracranial Activity of ROS1 TKIs
Treatment Strategy of ROS1-Rearranged NSCLC in TKI-Naive Patient
Case: Treatment Selection for ROS1-Rearranged NSCLC Patient with Brain Metastases
Current Guidelines and Real-World Evidence for ROS1 Testing in NSCLC
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education